In reply

Oncologist. 2013;18(4):e18. doi: 10.1634/theoncologist.2012-0421. Epub 2013 Apr 10.

Abstract

This reply to the letter by Hubiche et al. further discusses the hypothesis that geographic tongue is a novel entity related to bevacizumab therapy.

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / adverse effects*
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Female
  • Humans
  • Male
  • Mouth Mucosa / drug effects*
  • Tongue / drug effects*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized